The clinical practice guidelines also include a section on special considerations during the ongoing COVID-19 pandemic, touching on topics such as the differential diagnosis of irAEs versus COVID-19 and vaccination. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group J Clin Oncol 2021; doi:10.1200/JCO.21.01440

The COVID-19 Vaccination Advisory Committee of the US National Comprehensive Cancer Network has provided preliminary recommendations for COVID-19 vaccinations in people with cancer.

A survey of women with breast cancer in Mexico has revealed the key factors associated with COVID-19 vaccine hesitancy as well as factors that would motivate them to be vaccinated.

The COVID-19 pandemic has had a major effect on the professional and personal lives of oncologists, suggests a survey-based study.

However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.

Thoracic oncology nurse practitioner Beth Sandy explains how the coronavirus pandemic is affecting cancer patient care and how strategies such as telemedicine are coming into their own.

Genitourinary oncologists Cora Sternberg and Axel Merseburger share their experience of managing cancer patients during the COVID-19 pandemic, comparing perspectives from a US and German stand point.

Gilberto Lopes discusses the impact of the COVID-19 pandemic on the management of patients with lung cancer and outlines the measures being implemented to minimize the risk for patients.

The guidance outlines groups that may be at specific risk for acquiring COVID-19, symptoms to watch out for, and steps that should be taken in the event of these symptoms developing.

Click through for more information on these recommendations

Oncologists from the UK have jointly launched the UK Coronavirus Cancer Monitoring Project to collate data on cancer patients who acquire COVID-19.

An analysis of cancer patients with comorbid COVID-19 in Wuhan, China, has identified factors associated with an increased risk for a more severe clinical course.

A stage- and subtype-specific approach for the management of breast cancer during the COVID-19 outbreak has been published in JCO Oncology Practice .

Two sets of guidance on the care of lung cancer patients during the COVID-19 pandemic have been issued.

ASCO has issued guidance to support oncology practices as they recommence more routine care following the gradual easing of restrictions related to the COVID-19 pandemic.

ESMO has issued guidance for patients with cancer on the possible impact of COVID-19 on their care.

However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.